Supplement Scholar
Reproductive / HPG

Triptorelin

Research compound. This is not a dietary supplement. Unless it is identified as an approved prescription drug, it is not approved by the FDA for human use. This page summarizes published research for education only; we do not sell it or link to sellers.

Triptorelin. Long-acting GnRH agonist used to drive a large LH/FSH burst or, with sustained use, suppress them.

How it works. Strongly activates GnRH receptors, producing an initial flare of LH/FSH and testosterone, then chronic suppression with sustained dosing.

What the research supports. 2 graded claims. Strongest: Useful diagnostic and oncology applications (preclinical).

Hormonal impact. Effects on LH / FSH, Testosterone / Estradiol, HPG axis (chronic).

Side effects and interactions. 1 medication interaction listed. Serious: Tumor flare in hormone-sensitive cancers without anti-androgen cover.

Stacking. Pairs well with Oncology specialist oversight. Avoid combining with Unsupervised use.

Common forms. Available as Subcutaneous or intramuscular injection (depot formulations).

Community. Experiences from people who have tried Triptorelin. Anecdotes are not medical advice.

Triptorelin. Long-acting GnRH agonist used to drive a large LH/FSH burst or, with sustained use, suppress them.

Molecular structureC64H82N18O13 · 1311.4 g/mol

What it is

Triptorelin is a synthetic decapeptide GnRH agonist with much greater receptor affinity and resistance to degradation than native GnRH.

How it works

Strongly activates GnRH receptors, producing an initial flare of LH/FSH and testosterone, then chronic suppression with sustained dosing.

Pathways

  • GnRH receptor agonism
  • Receptor desensitization with sustained exposure

Effects

  • ↑Acute LH/FSH and testosterone (flare) increases
  • ⊘HPG axis with chronic depot dosing inhibits

What the research supports

Useful diagnostic and oncology applicationspreclinical
Can prompt HPG restart in some protocolspreclinical

Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.

Hormonal impact

↑LH / FSHincreases
↑Testosterone / Estradiolincreases
↓HPG axis (chronic)decreases

Side effects & interactions

Common side effects

  • Hot flashes
  • Injection-site reactions
  • Mood changes

Serious

  • Tumor flare in hormone-sensitive cancers without anti-androgen cover

Medication interactions

Anti-androgensmoderate

Used together to prevent tumor flare during initiation.

Check any supplement–medication combination with your pharmacist before starting.

Combines with

Pairs well

  • Oncology specialist oversightCancer use is the dominant clinical context.

Avoid combining

  • Unsupervised usePowerful HPG effects with both stimulation and suppression patterns.

Common forms

  • Subcutaneous or intramuscular injection (depot formulations)

Discussion

Loading discussion…